Inside the New GLP-1 Insights Feature GLP-1 Insights is a new experience inside the Oura App built specifically for members on GLP-1 medications
Development was carried forward by Metabolic Pharmaceuticals in collaboration with Monash University, with the stated goal of isolating the lipolytic properties of full-length HGH while eliminating its growth-promoting, IGF-1-elevating, and insulin-disrupting effects
The most common side effects of compounded semaglutide and compounded tirzepatide are similar to their brand-name counterparts and are typically gastrointestinal in nature, including: Nausea Vomiting Diarrhea Constipation Bloating or gas Decreased appetite or early satiety These side effects are usually mild to moderate and tend to improve over time, especially with gradual dose escalation under provider supervision
At a physical level, these include anemia, exhaustion, loss of appetite, nerve pain, muscle tremor, coordination disorders, and tingling or a sense of numbness in the legs